Literature DB >> 22036147

Incorporation of bovine-based structural bone grafts used in reconstructive foot surgery.

Naohiro Shibuya1, Daniel C Jupiter, Lacey D Clawson, Javier La Fontaine.   

Abstract

Timely incorporation of bone grafts is essential to the structural rigidity in most foot and ankle surgeries. Although bovine-based xenografts possess some of the key features necessary for foot and ankle surgery, the studies evaluating the efficacy of these grafts are limited. The aim of the present study was to determine the incorporation rate of bovine-based bone grafts in foot surgery. A total of 22 patients who had undergone reconstructive foot surgery using 31 bovine-based xenografts were identified, and the rate of radiographic incorporation of the grafts was evaluated. A survival analysis was used to show the trend of the incorporation of the xenografts over time. Of the 21 grafts observed for at least 12 weeks, none showed radiographic graft incorporation by 12 weeks. The analogous numbers for 24, 36, and 48 weeks were 3 (20%) of 15, 4 (31%) of 13, and 3 (27%) of 11 grafts. A total of 19 (61.29%) of the 31 grafts studied were never observed to have incorporated radiographically, for the entire observation period. A Kaplan-Meier estimate revealed the median interval to graft incorporation was 56 weeks. Compared with previous studies, which investigated the incorporation of other types of grafts, such as autograft and allografts, we believe that xenografts incorporate more slowly. For this reason, such grafts might not be ideal for use in reconstructive foot surgery.
Copyright © 2012 American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22036147     DOI: 10.1053/j.jfas.2011.09.008

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  5 in total

1.  Reconstruction of iliac crest with bovine cancellous allograft after bone graft harvest for symphysis pubis arthrodesis.

Authors:  Konstantinos G Makridis; Mudussar Abrar Ahmad; Nikolaos K Kanakaris; Evangelos M Fragkakis; Peter V Giannoudis
Journal:  Int Orthop       Date:  2012-05-22       Impact factor: 3.075

2.  Characterisation and evaluation of the regenerative capacity of Stro-4+ enriched bone marrow mesenchymal stromal cells using bovine extracellular matrix hydrogel and a novel biocompatible melt electro-written medical-grade polycaprolactone scaffold.

Authors:  C Black; J M Kanczler; M C de Andrés; L J White; F M Savi; O Bas; S Saifzadeh; J Henkel; A Zannettino; S Gronthos; M A Woodruff; D W Hutmacher; R O C Oreffo
Journal:  Biomaterials       Date:  2020-04-01       Impact factor: 12.479

3.  Sr and Mg Doped Bi-Phasic Calcium Phosphate Macroporous Bone Graft Substitutes Fabricated by Robocasting: A Structural and Cytocompatibility Assessment.

Authors:  Cristina Besleaga; Bo Nan; Adrian-Claudiu Popa; Liliana Marinela Balescu; Liviu Nedelcu; Ana Sofia Neto; Iuliana Pasuk; Lucia Leonat; Gianina Popescu-Pelin; José M F Ferreira; George E Stan
Journal:  J Funct Biomater       Date:  2022-08-23

4.  A Decellularized Porcine Xenograft-Derived Bone Scaffold for Clinical Use as a Bone Graft Substitute: A Critical Evaluation of Processing and Structure.

Authors:  Daniel N Bracey; Thorsten M Seyler; Alexander H Jinnah; Mark O Lively; Jeffrey S Willey; Thomas L Smith; Mark E Van Dyke; Patrick W Whitlock
Journal:  J Funct Biomater       Date:  2018-07-12

Review 5.  Use of in vitro bone models to screen for altered bone metabolism, osteopathies, and fracture healing: challenges of complex models.

Authors:  Sabrina Ehnert; Helen Rinderknecht; Romina H Aspera-Werz; Victor Häussling; Andreas K Nussler
Journal:  Arch Toxicol       Date:  2020-09-10       Impact factor: 5.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.